Pharmacological DYRK1A inhibition has been mostly realised through EGCG treatment, with conflicting results having been published regarding the effect of EGCG on cognitive impairment in Dyrk1a transgenic mice and in Ts65Dn mice. Here, DYRK1A is linked to Cognitive impairment.